The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Alcoholic Liver Diseases Treatment Market Research Report 2025
Synopsis
Alcoholic liver diseases are the result of overconsumption of alcohol, which damages the liver, leading to liver cirrhosis, inflammation, and liver scarring.
The global Alcoholic Liver Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alcoholic Liver Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alcoholic Liver Diseases Treatment.
Report Scope
The Alcoholic Liver Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alcoholic Liver Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alcoholic Liver Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson Services
Sanofi
Upsher-Smith Laboratories
Roche Holding
Novartis
GlaxoSmithKline
Pfizer
Bayer
Segment by Type
Alcoholic Fatty Liver Disease
Alcoholic Liver Hepatitis
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alcoholic Liver Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Alcoholic liver diseases are the result of overconsumption of alcohol, which damages the liver, leading to liver cirrhosis, inflammation, and liver scarring.
The global Alcoholic Liver Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alcoholic Liver Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alcoholic Liver Diseases Treatment.
Report Scope
The Alcoholic Liver Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alcoholic Liver Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alcoholic Liver Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson Services
Sanofi
Upsher-Smith Laboratories
Roche Holding
Novartis
GlaxoSmithKline
Pfizer
Bayer
Segment by Type
Alcoholic Fatty Liver Disease
Alcoholic Liver Hepatitis
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alcoholic Liver Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alcoholic Liver Diseases Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Alcoholic Fatty Liver Disease
1.2.3 Alcoholic Liver Hepatitis
1.2.4 Others
1.3 Market by Application
1.3.1 Global Alcoholic Liver Diseases Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alcoholic Liver Diseases Treatment Market Perspective (2019-2030)
2.2 Alcoholic Liver Diseases Treatment Growth Trends by Region
2.2.1 Global Alcoholic Liver Diseases Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alcoholic Liver Diseases Treatment Historic Market Size by Region (2019-2024)
2.2.3 Alcoholic Liver Diseases Treatment Forecasted Market Size by Region (2025-2030)
2.3 Alcoholic Liver Diseases Treatment Market Dynamics
2.3.1 Alcoholic Liver Diseases Treatment Industry Trends
2.3.2 Alcoholic Liver Diseases Treatment Market Drivers
2.3.3 Alcoholic Liver Diseases Treatment Market Challenges
2.3.4 Alcoholic Liver Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alcoholic Liver Diseases Treatment Players by Revenue
3.1.1 Global Top Alcoholic Liver Diseases Treatment Players by Revenue (2019-2024)
3.1.2 Global Alcoholic Liver Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Alcoholic Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alcoholic Liver Diseases Treatment Revenue
3.4 Global Alcoholic Liver Diseases Treatment Market Concentration Ratio
3.4.1 Global Alcoholic Liver Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alcoholic Liver Diseases Treatment Revenue in 2023
3.5 Alcoholic Liver Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Alcoholic Liver Diseases Treatment Product Solution and Service
3.7 Date of Enter into Alcoholic Liver Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alcoholic Liver Diseases Treatment Breakdown Data by Type
4.1 Global Alcoholic Liver Diseases Treatment Historic Market Size by Type (2019-2024)
4.2 Global Alcoholic Liver Diseases Treatment Forecasted Market Size by Type (2025-2030)
5 Alcoholic Liver Diseases Treatment Breakdown Data by Application
5.1 Global Alcoholic Liver Diseases Treatment Historic Market Size by Application (2019-2024)
5.2 Global Alcoholic Liver Diseases Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alcoholic Liver Diseases Treatment Market Size (2019-2030)
6.2 North America Alcoholic Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024)
6.4 North America Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alcoholic Liver Diseases Treatment Market Size (2019-2030)
7.2 Europe Alcoholic Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024)
7.4 Europe Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alcoholic Liver Diseases Treatment Market Size (2019-2030)
8.2 Asia-Pacific Alcoholic Liver Diseases Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alcoholic Liver Diseases Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Alcoholic Liver Diseases Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alcoholic Liver Diseases Treatment Market Size (2019-2030)
9.2 Latin America Alcoholic Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024)
9.4 Latin America Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alcoholic Liver Diseases Treatment Market Size (2019-2030)
10.2 Middle East & Africa Alcoholic Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson Services
11.1.1 Johnson & Johnson Services Company Detail
11.1.2 Johnson & Johnson Services Business Overview
11.1.3 Johnson & Johnson Services Alcoholic Liver Diseases Treatment Introduction
11.1.4 Johnson & Johnson Services Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.1.5 Johnson & Johnson Services Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Alcoholic Liver Diseases Treatment Introduction
11.2.4 Sanofi Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Upsher-Smith Laboratories
11.3.1 Upsher-Smith Laboratories Company Detail
11.3.2 Upsher-Smith Laboratories Business Overview
11.3.3 Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Introduction
11.3.4 Upsher-Smith Laboratories Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.3.5 Upsher-Smith Laboratories Recent Development
11.4 Roche Holding
11.4.1 Roche Holding Company Detail
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Alcoholic Liver Diseases Treatment Introduction
11.4.4 Roche Holding Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.4.5 Roche Holding Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Alcoholic Liver Diseases Treatment Introduction
11.5.4 Novartis Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Alcoholic Liver Diseases Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Alcoholic Liver Diseases Treatment Introduction
11.7.4 Pfizer Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Alcoholic Liver Diseases Treatment Introduction
11.8.4 Bayer Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024)
11.8.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Alcoholic Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Alcoholic Fatty Liver Disease
Table 3. Key Players of Alcoholic Liver Hepatitis
Table 4. Key Players of Others
Table 5. Global Alcoholic Liver Diseases Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Alcoholic Liver Diseases Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Alcoholic Liver Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Alcoholic Liver Diseases Treatment Market Share by Region (2019-2024)
Table 9. Global Alcoholic Liver Diseases Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Alcoholic Liver Diseases Treatment Market Share by Region (2025-2030)
Table 11. Alcoholic Liver Diseases Treatment Market Trends
Table 12. Alcoholic Liver Diseases Treatment Market Drivers
Table 13. Alcoholic Liver Diseases Treatment Market Challenges
Table 14. Alcoholic Liver Diseases Treatment Market Restraints
Table 15. Global Alcoholic Liver Diseases Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Alcoholic Liver Diseases Treatment Market Share by Players (2019-2024)
Table 17. Global Top Alcoholic Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcoholic Liver Diseases Treatment as of 2023)
Table 18. Ranking of Global Top Alcoholic Liver Diseases Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Alcoholic Liver Diseases Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alcoholic Liver Diseases Treatment Product Solution and Service
Table 22. Date of Enter into Alcoholic Liver Diseases Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alcoholic Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Alcoholic Liver Diseases Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Alcoholic Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Alcoholic Liver Diseases Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Alcoholic Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Alcoholic Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Alcoholic Liver Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Alcoholic Liver Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Alcoholic Liver Diseases Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Alcoholic Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Alcoholic Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Alcoholic Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Alcoholic Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Johnson & Johnson Services Company Detail
Table 48. Johnson & Johnson Services Business Overview
Table 49. Johnson & Johnson Services Alcoholic Liver Diseases Treatment Product
Table 50. Johnson & Johnson Services Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 51. Johnson & Johnson Services Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Alcoholic Liver Diseases Treatment Product
Table 55. Sanofi Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Upsher-Smith Laboratories Company Detail
Table 58. Upsher-Smith Laboratories Business Overview
Table 59. Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Product
Table 60. Upsher-Smith Laboratories Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 61. Upsher-Smith Laboratories Recent Development
Table 62. Roche Holding Company Detail
Table 63. Roche Holding Business Overview
Table 64. Roche Holding Alcoholic Liver Diseases Treatment Product
Table 65. Roche Holding Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 66. Roche Holding Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Alcoholic Liver Diseases Treatment Product
Table 70. Novartis Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. GlaxoSmithKline Company Detail
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Alcoholic Liver Diseases Treatment Product
Table 75. GlaxoSmithKline Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Alcoholic Liver Diseases Treatment Product
Table 80. Pfizer Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Bayer Company Detail
Table 83. Bayer Business Overview
Table 84. Bayer Alcoholic Liver Diseases Treatment Product
Table 85. Bayer Revenue in Alcoholic Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 86. Bayer Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alcoholic Liver Diseases Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alcoholic Liver Diseases Treatment Market Share by Type: 2023 VS 2030
Figure 3. Alcoholic Fatty Liver Disease Features
Figure 4. Alcoholic Liver Hepatitis Features
Figure 5. Others Features
Figure 6. Global Alcoholic Liver Diseases Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Alcoholic Liver Diseases Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Alcoholic Liver Diseases Treatment Report Years Considered
Figure 14. Global Alcoholic Liver Diseases Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Alcoholic Liver Diseases Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Alcoholic Liver Diseases Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Alcoholic Liver Diseases Treatment Market Share by Players in 2023
Figure 18. Global Top Alcoholic Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcoholic Liver Diseases Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Alcoholic Liver Diseases Treatment Revenue in 2023
Figure 20. North America Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Alcoholic Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 22. United States Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Alcoholic Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 26. Germany Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Alcoholic Liver Diseases Treatment Market Share by Region (2019-2030)
Figure 34. China Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Alcoholic Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Alcoholic Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Alcoholic Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Johnson & Johnson Services Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 50. Upsher-Smith Laboratories Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 51. Roche Holding Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Alcoholic Liver Diseases Treatment Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
